No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

byKathleen Lau

April 23, 2022

in StudyGraphics

Reading Time: 1 min read

Widespread population immunity of Covid-19 observed in South Africa before Omicron wave

RelatedReports

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

June 29, 2022

StudyGraphics

#VisualAbstract Oral azacitidine (CC-486) plus R-CHOP shows an acceptable safety profile in untreated diffuse large B-cell lymphoma

March 3, 2022

Chronic Disease

Epcoritamab shows promising response rates seen in relapsed or refractory non-Hodgkin lymphoma

December 2, 2021

$#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma$

StudyGraphics

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

December 2, 2021

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Awake prone positioning may not offer clinical benefits among patients hospitalized with COVID-19-associated hypoxemia

Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse

Marginalized identities, mistreatment, discrimination, and burnout among US medical students

2 Minute Medicine Rewind April 25, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports